Spinocerebellar ataxias (SCAs) caused by common mutations.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
10 2021
Historique:
received: 09 06 2021
accepted: 21 06 2021
pubmed: 18 8 2021
medline: 4 2 2022
entrez: 17 8 2021
Statut: ppublish

Résumé

The term SCA refers to a phenotypically and genetically heterogeneous group of autosomal dominant spinocerebellar ataxias. Phenotypically they present as gait ataxia frequently in combination with dysarthria and oculomotor problems. Additional signs and symptoms are common and can include various pyramidal and extrapyramidal signs and intellectual impairment. Genetic causes of SCAs are either repeat expansions within disease genes or common mutations (point mutations, deletions, insertions etc.). Frequently the two types of mutations cause indistinguishable phenotypes (locus heterogeneity). This article focuses on SCAs caused by common mutations. It describes phenotype and genotype of the presently 27 types known and discusses the molecular pathogenesis in those 21 types where the disease gene has been identified. Apart from the dominant types, the article also summarizes findings in a variant caused by mutations in a mitochondrial gene. Possible common disease mechanisms are considered based on findings in the various SCAs described.

Identifiants

pubmed: 34401960
doi: 10.1007/s10048-021-00662-5
pii: 10.1007/s10048-021-00662-5
pmc: PMC8426233
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-250

Informations de copyright

© 2021. The Author(s).

Références

Neurol Genet. 2016 Aug 18;2(5):e94
pubmed: 27583304
PLoS Genet. 2007 Jun;3(6):e108
pubmed: 17590087
Pflugers Arch. 2010 Feb;459(3):369-75
pubmed: 19823866
Parkinsonism Relat Disord. 2019 Aug;65:91-96
pubmed: 31126790
PLoS Genet. 2018 Dec 10;14(12):e1007844
pubmed: 30532139
Cerebellum. 2012 Sep;11(3):630-9
pubmed: 20480274
Am J Hum Genet. 2003 Apr;72(4):839-49
pubmed: 12644968
Front Biosci. 2005 Jan 01;10:216-35
pubmed: 15574363
J Child Neurol. 2013 Oct;28(10):1292-5
pubmed: 22914369
Cell. 2015 Mar 12;160(6):1087-98
pubmed: 25768905
FEBS Lett. 1995 Sep 18;372(1):59-64
pubmed: 7556643
Neuroreport. 1999 Feb 25;10(3):619-24
pubmed: 10208600
J Biochem. 2002 Nov;132(5):683-7
pubmed: 12417016
FEBS Lett. 1997 Dec 22;420(1):47-53
pubmed: 9450548
Hum Mol Genet. 2012 Dec 15;21(26):5472-83
pubmed: 23001565
JAMA Neurol. 2015 Jul;72(7):797-805
pubmed: 26010696
PLoS One. 2015 Mar 10;10(3):e0116599
pubmed: 25756792
Neurology. 2008 Aug 19;71(8):547-51
pubmed: 18579805
Environ Health Perspect. 1999 Feb;107 Suppl 1:25-35
pubmed: 10229704
Ann Neurol. 2001 Aug;50(2):234-9
pubmed: 11506407
Aging Cell. 2007 Jun;6(3):337-50
pubmed: 17328689
Neurogenetics. 2020 Jan;21(1):51-58
pubmed: 31741143
Neurobiol Dis. 2003 Jul;13(2):147-57
pubmed: 12828938
Arch Dermatol. 1972 Aug;106(2):183-8
pubmed: 5048218
Neurology. 2001 Jan 23;56(2):234-8
pubmed: 11160961
Eur J Med Genet. 2019 Mar;62(3):172-176
pubmed: 30017992
Mol Cell Neurosci. 2017 Oct;84:29-35
pubmed: 28765051
Am J Hum Genet. 2014 Aug 7;95(2):209-17
pubmed: 25065913
Hum Genet. 2002 Oct;111(4-5):388-93
pubmed: 12384780
Brain. 2004 May;127(Pt 5):1172-81
pubmed: 14998916
Clin Genet. 2013 Mar;83(3):269-73
pubmed: 22554020
Am J Hum Genet. 2000 Jul;67(1):229-35
pubmed: 10820125
Mov Disord. 2015 Feb;30(2):262-6
pubmed: 25545641
Hum Mutat. 2010 Oct;31(10):1117-24
pubmed: 20725928
J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1229-32
pubmed: 20667868
Neurol Genet. 2021 Mar 26;7(3):e581
pubmed: 33884300
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):408-11
pubmed: 18996908
Ann Neurol. 2005 Nov;58(5):720-9
pubmed: 16193476
Eur J Hum Genet. 2005 Jan;13(1):118-20
pubmed: 15470364
Cell. 2012 Nov 9;151(4):847-858
pubmed: 23141541
Arch Neurol. 2011 May;68(5):637-43
pubmed: 21555639
Mol Cell Proteomics. 2012 Aug;11(8):215-29
pubmed: 22645316
Ann Neurol. 2005 Mar;57(3):349-54
pubmed: 15732118
Curr Biol. 2012 Oct 9;22(19):1800-7
pubmed: 22885064
Ann Neurol. 2012 Dec;72(6):859-69
pubmed: 23280837
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Hum Mutat. 2019 May;40(5):499-515
pubmed: 30763462
J Cell Biol. 2015 Aug 31;210(5):737-51
pubmed: 26323690
Brain. 2010 Dec;133(Pt 12):3510-8
pubmed: 21106500
Brain. 2015 Feb;138(Pt 2):276-83
pubmed: 25497598
Cerebellum. 2014 Oct;13(5):628-36
pubmed: 24797279
Sci Rep. 2017 Feb 27;7:43468
pubmed: 28240305
Mol Cell Neurosci. 2002 Aug;20(4):563-78
pubmed: 12213440
J Neurol. 2021 Dec;268(12):4866-4873
pubmed: 34037856
Physiol Rev. 2006 Jan;86(1):369-408
pubmed: 16371601
Neurology. 1999 Oct 12;53(6):1355-7
pubmed: 10522902
Ann Neurol. 2012 Dec;72(6):870-80
pubmed: 23280838
Mol Biol Cell. 2003 Jul;14(7):2645-54
pubmed: 12857853
Neurology. 2004 Feb 24;62(4):648-51
pubmed: 14981189
Cerebellum. 2013 Dec;12(6):932-6
pubmed: 23912307
Cell. 2018 Feb 22;172(5):924-936.e11
pubmed: 29474920
Brain. 2017 Nov 1;140(11):2860-2878
pubmed: 29053796
Neurology. 2018 Nov 20;91(21):e1988-e1998
pubmed: 30381368
Neurotherapeutics. 2019 Apr;16(2):263-286
pubmed: 30607747
J Neurol. 2001 Feb;248(2):113-20
pubmed: 11284128
J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):883-6
pubmed: 22577227
Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9376-E9385
pubmed: 29078305
Ann Neurol. 2000 Aug;48(2):156-63
pubmed: 10939565
Eur J Hum Genet. 2018 Jul;26(7):928-929
pubmed: 29795474
J Med Genet. 2014 Sep;51(9):590-5
pubmed: 25062847
Biomed Res Int. 2015;2015:575170
pubmed: 25950000
J Biol Chem. 2018 Apr 6;293(14):5220-5229
pubmed: 29453282
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11404-9
pubmed: 10500189
Mov Disord. 2015 Feb;30(2):284-6
pubmed: 25477146
J Med Genet. 2011 Jun;48(6):407-12
pubmed: 21367767
Nat Genet. 1994 Nov;8(3):280-4
pubmed: 7874171
Am J Hum Genet. 2003 Jan;72(1):191-9
pubmed: 12489043
Neurology. 2004 Jan 27;62(2):327-9
pubmed: 14745083
Nat Genet. 2006 Apr;38(4):447-51
pubmed: 16501573
Biochem J. 2013 Sep 1;454(2):259-65
pubmed: 23734863
Mol Cell Neurosci. 2003 Aug;23(4):600-13
pubmed: 12932440
Brain. 2006 Jan;129(Pt 1):235-42
pubmed: 16251216
Neurology. 2006 Oct 10;67(7):1236-41
pubmed: 17030759
Am J Hum Genet. 2011 Jul 15;89(1):121-30
pubmed: 21683323
J Neurol. 2019 Feb;266(2):533-544
pubmed: 30284037
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12957-8
pubmed: 11058149
Brain. 2014 Oct;137(Pt 10):2657-63
pubmed: 25070513
Nat Genet. 2010 Apr;42(4):313-21
pubmed: 20208537
Parkinsonism Relat Disord. 2017 Dec;45:85-89
pubmed: 28947073
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14158-63
pubmed: 9826670
J Neurophysiol. 1998 Feb;79(2):1081-91
pubmed: 9463463
JAMA Neurol. 2014 Apr;71(4):470-5
pubmed: 24566826
Ann Neurol. 2004 Jan;55(1):97-104
pubmed: 14705117
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9850-7
pubmed: 8790420
Nat Genet. 2007 Dec;39(12):1434-6
pubmed: 18037885
Cell. 2016 Apr 7;165(2):434-448
pubmed: 26997484
Neurology. 2005 Oct 11;65(7):1111-3
pubmed: 16135769
Neurol Sci. 2021 Dec;42(12):5195-5203
pubmed: 33797620
Nat Genet. 2006 Feb;38(2):184-90
pubmed: 16429157
Am J Med Genet A. 2015 Aug;167A(8):1916-20
pubmed: 25900906
Nucleic Acids Res. 2005 Oct 06;33(18):5740-8
pubmed: 16214807
Nature. 2011 Sep 21;478(7367):57-63
pubmed: 21937992
Hum Mol Genet. 2008 Dec 15;17(24):3847-53
pubmed: 18801880
Neurology. 2001 Nov 27;57(10):1913-5
pubmed: 11723290
Neurology. 2014 Oct 21;83(17):1554-61
pubmed: 25253745
Acta Neuropathol Commun. 2018 Sep 24;6(1):99
pubmed: 30249303
Am J Hum Genet. 2017 Jul 6;101(1):87-103
pubmed: 28686858
Brain. 2003 Jun;126(Pt 6):1293-9
pubmed: 12764052
Am J Hum Genet. 1999 Aug;65(2):420-6
pubmed: 10417284
Arch Neurol. 2002 Aug;59(8):1291-5
pubmed: 12164726
Brain. 2015 Jul;138(Pt 7):1817-32
pubmed: 25981959
Arch Neurol. 2004 Aug;61(8):1242-8
pubmed: 15313841
Am J Med Genet. 2002 May 8;114(4):450-7
pubmed: 11992570
Brain. 2004 Nov;127(Pt 11):2551-7
pubmed: 15306549
Am J Hum Genet. 2010 Nov 12;87(5):593-603
pubmed: 21035104
Am J Hum Genet. 2009 May;84(5):692-7
pubmed: 19409521
J Hum Genet. 2005;50(10):523-529
pubmed: 16189624

Auteurs

Ulrich Müller (U)

Institute of Human Genetics, JLU-Gießen, Schlangenzahl 14, 35392, Giessen, Germany. mueller.genetics@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH